Is Descovy a Controlled Substance? No

No. Descovy (emtricitabine and tenofovir alafenamide) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and emtricitabine and tenofovir alafenamide is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Descovy?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Descovy
Source	What it lists
FDA NDC directory	2 prescription listings from 1 labelers, none with a DEA schedule
DEA controlled substances list	emtricitabine and tenofovir alafenamide is not on the list

Descovy NDC listings

NDC listings for Descovy
NDC	Product	Form	Strength	Labeler	DEA schedule
61958-2005	DESCOVY	tablet	120 mg/1; 15 mg/1	Gilead Sciences, Inc.	None
61958-2002	DESCOVY	tablet	200 mg/1; 25 mg/1	Gilead Sciences, Inc.	None

Questions

Is Descovy a controlled substance?

No. Descovy (emtricitabine and tenofovir alafenamide) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and emtricitabine and tenofovir alafenamide is not on the DEA controlled substances list.

Is Descovy a narcotic?

No. Descovy (emtricitabine and tenofovir alafenamide) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor and Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.